Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Glycam1em1/Cya
Common Name:
Glycam1-KO
Product ID:
S-KO-02264
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Glycam1-KO
Strain ID
KOCMP-14663-Glycam1-B6N-VA
Gene Name
Glycam1
Product ID
S-KO-02264
Gene Alias
MC26; Sgp50; glyCAM-1
Background
C57BL/6NCya
NCBI ID
14663
Modification
Conventional knockout
Chromosome
15
Phenotype
MGI:95759
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Glycam1em1/Cya mice (Catalog S-KO-02264) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000228895
NCBI RefSeq
NM_001289587
Target Region
Exon 1~4
Size of Effective Region
~2.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Glycam1, short for glycosylation-dependent cell adhesion molecule 1, is a proteoglycan ligand for L-selectin. It is involved in modulating immune cell entry and has been associated with lymphocyte trafficking. It plays a role in the immune system and is also expressed in the mammary gland, suggesting functions in both immunological and lactation-related processes [2,3]. Genetic models, such as knockout mouse models, are valuable for studying its functions.

In a study on glaucoma in DBA/2J mice, a null allele of Glycam1 was generated. Radiation therapy usually inhibits monocyte entry into the optic nerve head, preventing retinal ganglion cell death and axon loss. However, DBA/2J mice with a Glycam1 null allele showed increased monocyte entry, as well as increased retinal ganglion cell death and axon loss after radiation therapy. This indicates that Glycam1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma [1].

In conclusion, Glycam1 has a role in modulating immune cell entry, as demonstrated by the gene knockout study in glaucoma. Its function as a negative regulator of extravasation may lead to new therapeutic strategies for conditions involving inflammation. Additionally, its expression in the mammary gland suggests potential functions in lactation-related processes, which warrants further research [1,2,3].

References:

1. Williams, Pete A, Braine, Catherine E, Foxworth, Nicole E, Cochran, Kelly E, John, Simon W M. 2017. GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma. In Journal of neuroinflammation, 14, 93. doi:10.1186/s12974-017-0868-8. https://pubmed.ncbi.nlm.nih.gov/28446179/

2. Groenen, M A, Dijkhof, R J, van der Poel, J J. . Characterization of a GlyCAM1-like gene (glycosylation-dependent cell adhesion molecule 1) which is highly and specifically expressed in the lactating bovine mammary gland. In Gene, 158, 189-95. doi:. https://pubmed.ncbi.nlm.nih.gov/7607540/

3. Nishimura, Toshihide. . Expression of potential lymphocyte trafficking mediator molecules in the mammary gland. In Veterinary research, 34, 3-10. doi:. https://pubmed.ncbi.nlm.nih.gov/12588680/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest